Spending on pharmaceutical and biotech projects in North America will rise 1.4% this year from 2017, according to Industrial Info's 2018 Global Industrial Outlook.


Annette Kreuger, Industrial Info's vice president of research for the Pharmaceutical-Biotech Industry, said, "An impact from favorable new tax laws is expected to boost capex investment, as more cash is readily available. New products and technologies are also a factor."


For related information, see February 13, 2018, article - It's LIVE! 2018 North American Pharma & Biotech Outlook Spotlights Nearly $20 Billion Potential in 2018 Capital Spending Kick-Offs.


The North American Spending Forecast for the Pharmaceutical and Biotech Industry in 2018 is part of Industrial Info's 2018 Global Industrial Outlook, which covers industries ranging from Alternative Fuels to Metals & Minerals.


For more information and updates, please subscribe to the IIR blog.



Leave a Comment


comments powered by Disqus


Recomended for you...

GMI Reveals Robust 24-Month Kickoff Outlook for Asia Power and Industrials

Industrial Info's Global Market Intelligence (GMI) Integrated Platform is tracking more than $3.89 trillion in projects this month…

Global Metals & Minerals Planned Project Spending at $1.68 Trillion

Researched by Industrial Info Resources (Sugar Land, Texas)--The total pipeline of planned capital and maintenance project activity within…